BMI View: The Moroccan government's strategy of introducing pharma-clusters in an attempt to
strengthen the domestic pharmaceutical industry will see the market develop into a more attractive
investment destination for multinational drugmakers. The use of pharma-clust ..."
BMI View: The Moroccan government's increasing efforts to improve healthcare coverage will be the
largest driver of pharmaceutical growth in the country over the coming years. Morocco has seen recent
improvements towards its regulatory standards; however, the governme ..."
BMI View: We hold an optimistic outlook for the Moroccan pharmaceutical market despite the economic
slowdown over 2016. We expect the government's increasing efforts to improve healthcare coverage
coupled with the country's growing non-communicable disease burden will ..."
BMI View: The Moroccan government's decision to reimburse generic Sovaldi (sofosbuvir) along with the
incorporation of students into it medical coverage scheme highlights its commitment to increasing the
population's access to healthcare - a positive to drugmakers. Ho ..."
BMI View: Access to medicines in Morocco has been improving significantly over recent years with the
implementation of numerous drug price cuts and expanding health insurance coverage. However, the
proposed legislation to increase VAT on pharmaceuticals will negativel ..."
BMI View: Similar to other North African markets, Morocco's inclusion on PhRMA's Special 301
Submission for 2015 for intellectual property and pricing issues highlights the ongoing challenges that
multinational drugmakers face in the market. However, we expect innovat ..."
BMI View: A new wave of drug price cuts in Morocco and the implementation of the final stage of its
universal healthcare coverage programme will see an improvement in the population's access to medicines.
While increasing access to medicines is positive for drugmakers ..."
BMI View: Our outlook for Morocco's pharmaceutical market remains relatively optimistic over the shortto-
long term. Increased access to healthcare in Morocco following the implementation of the final phase of
its universal health insurance scheme will drive an increa ..."
BMI View: As Morocco's economic conditions improve towards the end of 2014 and the rate of decline in
pharmaceutical sales slows, we hold an overall positive outlook for the market over the medium-to-long
term, which will be driven by the growing middle class. However ..."
BMI View: Despite the Moroccan government announcing a new economic policy prioritising the
innovative biopharmaceutical industry as a strategic sector within the economy, unclear policy formation
processes and underdeveloped institutions will continue to cloud the co ..."